Top 5 Stock Picks of Glenn Greenberg’s Brave Warrior Capital

Page 5 of 5

1. Anthem, Inc. (NYSE:ANTM)

Brave Warrior Capital’s Stake Value: $584,538,000
Percentage of Brave Warrior Capital’s 13F Portfolio: 20.06%
Number of Hedge Fund Holders: 74

Anthem, Inc. (NYSE:ANTM) is a healthcare organization dedicated to improving people’s lives and making healthcare more accessible. Anthem’s connected enterprises serve more than 118 million people, including more than 45 million through its family of health plans. On June 28, Anthem received an official rebranding and started trading on the New York Stock Exchange under the new ticker code “ELV”.

Based on its 13F holdings for the second quarter of 2022, Brave Warrior Capital owned 1.21 million shares of Anthem, Inc. (NYSE:ANTM), valued at $584.54 million. First Eagle Investment Management is the leading stakeholder of Anthem, Inc. (NYSE:ANTM), with 2.01 million shares worth $970.47 million.

As of the end of the second quarter, 74 hedge funds in Insider Monkey’s database of 895 funds held stakes in Elevance Health Inc. (NYSE:ELV), compared to 69 funds in the previous quarter. On August 22, SVB Securities analyst Whit Mayo raised Elevance Health Inc. (NYSE:ELV) from ‘Market Perform’ to ‘Outperform,’ with a $580 price objective, up from $490.

ClearBridge Investments, in its Q4 2021 investor letter, mentioned and discussed its stance on the firm. Here is what the fund said:

“The quarter also saw strong showings from Anthem; has been operating well and is a key player in the evolution of health care insurance and delivery, providing more integrated and cost-effective solutions and receiving a tailwind from an aging population. The company tends to be volatile based on changes in medical loss ratios (MLR), though we view this volatility as a short term for business models that are able to reprice policies relatively quickly. We added significantly to the position during the year.”

You can also take a peek at Top 10 Stock Picks of Cinctive Capital Management and Top 10 Stock Picks of Mark Gallogly’s Centerbridge Partners.

Page 5 of 5